Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.56 |
| ▸ | ITGAV | P06756 | 3/20 | 0.49 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.49 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.49 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.49 |
| ▸ | CTSG | P08311 | 1/20 | 0.49 |
| ▸ | MC4R | P32245 | 4/20 | 0.49 |
| ▸ | MC5R | P33032 | 4/20 | 0.49 |
| ▸ | MC3R | P41968 | 4/20 | 0.49 |
| ▸ | MC1R | Q01726 | 4/20 | 0.49 |
| ▸ | CD2 | P06729 | 1/20 | 0.48 |
| ▸ | CD58 | P19256 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | KDM4A | O75164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24454392 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BCACNA1BITGAVITGB5 | |
| SCHEMBL19018807 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BCACNA1BITGAVITGB5 | |
| SCHEMBL15308347 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BCACNA1BITGAVITGB5 | |
| SCHEMBL23839922 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BCACNA1BITGAVITGB5 | |
| SCHEMBL29393726 | 0.96 | ITGB3 (0.59) | ITGB3ITGA2BCACNA1BITGAVITGB5 | |
| SCHEMBL16938095 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2BITGAVITGB5ITGB1 | |
| SCHEMBL18968795 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2BITGAVITGB5ITGB1 | |
| SCHEMBL13107808 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2BITGAVITGB5ITGB1 | |
| SCHEMBL21475019 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2BITGAVITGB5ITGB1 | |
| SCHEMBL19581486 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2BITGAVITGB5ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220160905-A1 | FLUORINATION METHOD | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-05-26 | — | — | US | claimed |
| US-20260108638-A1 | 68GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS | RIGSHOSPITALET (DK) | 2026-04-23 | — | — | US | disclosed |
| US-12521454-B2 | 68Ga- and 64Cu-NODAGA-E[c(RGDyK)]2 for use as PET tracers in the imaging of angiogenesis in humans | RIGSHOSPITALET (DK) | 2026-01-13 | — | — | US | disclosed |
| WO-2025097185-A1 | COMPOSITIONS AND METHODS FOR PREVENTING MICROBIAL-MEDIATED DISEASE | CUTLER RICHELLE (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-4527393-A1 | SURFACE-MODIFIED NANODIAMOND | Kyoto University (JP) | 2025-03-26 | — | — | EP | disclosed |
| CN-119173267-A | Surface-modified nanodiamond | 国立大学法人京都大学 | 2024-12-20 | — | — | CN | disclosed |
| US-20240408220-A1 | PEPTIDE DENDRONS AND METHODS OF USE THEREOF | ASTRAZENECA PHARMACEUTICALS LP | 2024-12-12 | — | — | US | disclosed |
| EP-4412662-A1 | PEPTIDE DENDRONS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023223962-A1 | SURFACE-MODIFIED NANODIAMOND | 国立大学法人京都大学 | 2023-11-23 | — | — | WO | disclosed |
| US-20230303577-A1 | TEMOZOLOMIDE ANALOGS AND METHODS OF USE | ST. JOHN'S CANCER INSTITUTE (US) | 2023-09-28 | — | — | US | disclosed |
| US-9234007-B2 | RGD mimetic γ-AApeptides and methods of use | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-01-12 | — | — | US | disclosed |
| US-20150291608-A1 | NOVEL TETRAAZA MACROCYCLIC COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-10-15 | — | — | US | disclosed |
| US-9079867-B2 | Polyazamacrocyclic compound, and a production method and a biomedical use therefor | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-07-14 | — | — | US | disclosed |
| US-9079867-B2 | Polyazamacrocyclic compound, and a production method and a biomedical use therefor | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-07-14 | — | — | US | disclosed |
| US-9061078-B2 | Tetraaza macrocyclic compound, preparation method thereof and use thereof | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-06-23 | — | — | US | disclosed |
| WO-2014197763-A1 | MOLECULAR DESIGN TOWARD DUAL-MODALITY PROBES FOR RADIOISOTOPE-BASED IMAGING (PET OR SPECT) AND MRI | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEAS SYSTEM (US) | 2014-12-11 | — | — | WO | disclosed |
| US-20130189185-A1 | Boron-Based Dual Imaging Probes, Compositions and Methods for Rapid Aqueous F-18 Labeling, and Imaging Methods Using Same | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130004423-A1 | POLYAZAMACROCYCLIC COMPOUND, AND A PRODUCTION METHOD AND A BIOMEDICAL USE THEREFOR | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2013-01-03 | — | — | US | disclosed |
| US-20120219495-A1 | NOVEL TETRAAZA MACROCYCLIC COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2012-08-30 | — | — | US | disclosed |
| US-6537520-B1 | Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108638-A1 | 68GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS | VEGFA, FLT1, HIF1A | ITGB3 324/4885ITGA2B 630/4885CACNA1B 1246/4885 |
| US-20150291608-A1 | NOVEL TETRAAZA MACROCYCLIC COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF | TBCA, NBAS, BMP2 | ITGB3 3342/4885ITGA2B 1874/4885CACNA1B 1226/4885 |
| US-20220160905-A1 | FLUORINATION METHOD | AFF2, AFF1, AFF4 | ITGB3 1236/4885ITGA2B 1633/4885CACNA1B 3211/4885 |
| US-20130004423-A1 | POLYAZAMACROCYCLIC COMPOUND, AND A PRODUCTION METHOD AND A BIOMEDICAL USE THEREFOR | SLC39A11, VIP, PBDC1 | ITGB3 4455/4885ITGA2B 3728/4885CACNA1B 1503/4885 |
| US-20230303577-A1 | TEMOZOLOMIDE ANALOGS AND METHODS OF USE | MGMT, TOP2B, IDH3B | ITGB3 1566/4885ITGA2B 1227/4885CACNA1B 1830/4885 |
| US-20130189185-A1 | Boron-Based Dual Imaging Probes, Compositions and Methods for Rapid Aqueous F-18 Labeling, and Imaging Methods Using Same | CBR3, SLC38A7, SLC6A19 | ITGB3 2831/4885ITGA2B 3901/4885CACNA1B 569/4885 |
| US-20120219495-A1 | NOVEL TETRAAZA MACROCYCLIC COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF | TBCA, NBAS, BMP2 | ITGB3 3342/4885ITGA2B 1874/4885CACNA1B 1226/4885 |
| US-20240408220-A1 | PEPTIDE DENDRONS AND METHODS OF USE THEREOF | VIP, NGLY1, PROKR1 | ITGB3 630/4885ITGA2B 882/4885CACNA1B 4139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.